Biologics Safety Testing Market contains market size and forecasts of Biologics Safety Testing in Global, including the following market information:
- Global Biologics Safety Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biologics Safety Testing market was valued at 2538.9 million in 2021 and is projected to reach US$ 3990.8 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Endotoxin Tests Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologics Safety Testing include Lonza Group, Charles River, Merck, SGS, WuXi AppTec, Thermo Fisher Scientific, Sartorius, Cytovance Biologics and Pace Analytical Services and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biologics Safety Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics Safety Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biologics Safety Testing Market Segment Percentages, by Type, 2021 (%)
- Endotoxin Tests
- Sterility Tests
- Cell Line Authentication and Characterization Tests
- Bioburden Tests
- Cell Line Authentication
- Residual Host Contaminant Detection Tests
- Adventitious Agent Detection Tests
- Others
Global Biologics Safety Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biologics Safety Testing Market Segment Percentages, by Application, 2021 (%)
- Pharmaceutical
- Medical Research
Global Biologics Safety Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biologics Safety Testing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biologics Safety Testing revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Biologics Safety Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Lonza Group
- Charles River
- Merck
- SGS
- WuXi AppTec
- Thermo Fisher Scientific
- Sartorius
- Cytovance Biologics
- Pace Analytical Services
- Toxikon